Menu

Markets

Research

News

Learn

AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Kiniksa Pharmaceuticals International, plc KNSA

Full chart Compare
Set alert

Price alert · KNSA

All alert types
93.86 USD +5.52 (+6.25%)

At closeNov 9, 2026, 4:18 AM EST

93.00 -0.86 -0.92%

Pre-market · Nov 9, 4:18 AM ET

88.41 Day range 94.48
37.02 52-week range 98.48
YTD
+127.54%
1 year
+142.97%

Financial health

Altman Z-Score

17.80 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

6 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

Rating

B3 / 5 overall

  • DCF 1
  • Return on Equity 4
  • Return on Assets 5
  • Debt / Equity 4
  • P/E 1
  • P/B 1

Valuation

P/E 51.6×
FY 2016: -26.3×FY 2017: -9.7×FY 2018: -8.0×FY 2019: -3.7×FY 2020: -6.8×FY 2021: -5.1×FY 2022: 5.7×FY 2023: 87.7×FY 2024: -33.0×FY 2025: 51.6×
FY 2016 5y median 5.7× FY 2025
P/S 4.5×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 20.9×FY 2022: 4.7×FY 2023: 4.5×FY 2024: 3.3×FY 2025: 4.5×
FY 2016 5y median 4.5× FY 2025
P/B 5.4×
FY 2016: -24.6×FY 2017: -7.0×FY 2018: -4.3×FY 2019: 2.7×FY 2020: 3.5×FY 2021: 4.4×FY 2022: 2.6×FY 2023: 2.8×FY 2024: 3.2×FY 2025: 5.4×
FY 2016 5y median 3.2× FY 2025
P/FCF 120×
FY 2016: -28.9×FY 2017: -12.6×FY 2018: -9.6×FY 2019: -3.7×FY 2020: -8.0×FY 2021: -5.5×FY 2022: 182×FY 2023: 93.3×FY 2024: 55.6×FY 2025: 120×
FY 2016 5y median 93.3× FY 2025
EV/EBITDA 32.1×
FY 2016: -24.0×FY 2017: -9.0×FY 2018: -4.8×FY 2019: -3.4×FY 2020: -6.4×FY 2021: -4.5×FY 2022: 68.7×FY 2023: -79.2×FY 2024: -36.0×FY 2025: 32.1×
FY 2016 5y median -4.5× FY 2025
EV/Sales 4.3×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 17.9×FY 2022: 4.2×FY 2023: 4.2×FY 2024: 2.9×FY 2025: 4.3×
FY 2016 5y median 4.2× FY 2025
FCF Yield 0.8%
FY 2016: -3.5%FY 2017: -8.0%FY 2018: -10.4%FY 2019: -27.0%FY 2020: -12.5%FY 2021: -18.2%FY 2022: 0.5%FY 2023: 1.1%FY 2024: 1.8%FY 2025: 0.8%
FY 2016 5y median 0.8% FY 2025

Profitability

Gross Margin 54.6%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 76.4%FY 2022: 89.6%FY 2023: 79.1%FY 2024: 85.6%FY 2025: 54.6%
FY 2016 5y median 79.1% FY 2025
Operating Margin 11.4%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: -406.4%FY 2022: 4.4%FY 2023: -9.3%FY 2024: -10.8%FY 2025: 11.4%
FY 2016 5y median -9.3% FY 2025
Net Margin 8.7%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: -409.7%FY 2022: 83.3%FY 2023: 5.2%FY 2024: -10.2%FY 2025: 8.7%
FY 2016 5y median 5.2% FY 2025
ROE 10.4%
FY 2016: 93.2%FY 2017: 72.3%FY 2018: 53.1%FY 2019: -71.8%FY 2020: -51.7%FY 2021: -85.3%FY 2022: 46.3%FY 2023: 3.2%FY 2024: -9.9%FY 2025: 10.4%
FY 2016 5y median 3.2% FY 2025
ROIC 8.2%
FY 2016: -44.3%FY 2017: -217.6%FY 2018: -38.6%FY 2019: -73.5%FY 2020: -49.2%FY 2021: -81.9%FY 2022: 2.3%FY 2023: 4.6%FY 2024: -9.5%FY 2025: 8.2%
FY 2016 5y median 2.3% FY 2025
ROA 7.7%
FY 2016: -42.5%FY 2017: -136.6%FY 2018: -32.1%FY 2019: -63.6%FY 2020: -46.2%FY 2021: -67.8%FY 2022: 39.9%FY 2023: 2.7%FY 2024: -7.4%FY 2025: 7.7%
FY 2016 5y median 2.7% FY 2025

Growth (YoY)

Revenue 60.1%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 471.2%FY 2023: 22.7%FY 2024: 56.6%FY 2025: 60.1%
FY 2016 FY 2025
Operating Income 269.3%
FY 2016: 0.0%FY 2017: -172.5%FY 2018: -65.4%FY 2019: -57.1%FY 2020: 7.4%FY 2021: 0.5%FY 2022: 106.2%FY 2023: -357.8%FY 2024: -81.0%FY 2025: 269.3%
FY 2016 FY 2025
EPS (diluted) 225.0%
FY 2016: 0.0%FY 2017: -170.3%FY 2018: -74.5%FY 2019: 14.3%FY 2020: 12.7%FY 2021: 11.9%FY 2022: 213.0%FY 2023: -92.3%FY 2024: -400.0%FY 2025: 225.0%
FY 2016 FY 2025
Free Cash Flow 0.0%
FY 2016: 0.0%FY 2017: -129.9%FY 2018: -71.6%FY 2019: -87.2%FY 2020: 15.3%FY 2021: -7.2%FY 2022: 103.9%FY 2023: 131.0%FY 2024: 92.9%FY 2025: 0.0%
FY 2016 FY 2025

Financial Health

Current Ratio 3.8×
FY 2016: 24.5×FY 2017: 2.7×FY 2018: 7.4×FY 2019: 8.7×FY 2020: 10.5×FY 2021: 4.4×FY 2022: 5.2×FY 2023: 4.3×FY 2024: 3.3×FY 2025: 3.8×
FY 2016 5y median 4.3× FY 2025
Quick Ratio 3.4×
FY 2016: 24.5×FY 2017: 2.7×FY 2018: 7.4×FY 2019: 8.7×FY 2020: 10.5×FY 2021: 4.3×FY 2022: 4.7×FY 2023: 3.9×FY 2024: 3.0×FY 2025: 3.4×
FY 2016 5y median 3.9× FY 2025
Debt / Equity 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA -1.7×
FY 2016: 2.3×FY 2017: 0.7×FY 2018: 2.8×FY 2019: 0.3×FY 2020: 0.7×FY 2021: 0.8×FY 2022: -8.7×FY 2023: 6.7×FY 2024: 5.0×FY 2025: -1.7×
FY 2016 5y median 0.8× FY 2025
Interest Coverage 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31